Back to Search Start Over

Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Authors :
Selvaraj, Senthil
Vaduganathan, Muthiah
Claggett, Brian L.
Miao, Zi Michael
Fang, James C.
Vardeny, Orly
Desai, Akshay S.
Shah, Sanjiv J.
Lam, Carolyn S.P.
Martinez, Felipe A.
Inzucchi, Silvio E.
de Boer, Rudolf A.
Petersson, Magnus
Langkilde, Anna Maria
McMurray, John J.V.
Solomon, Scott D.
Source :
JACC: Heart Failure; January 2023, Vol. 11 Issue: 1 p76-89, 14p
Publication Year :
2023

Abstract

Optimizing systolic blood pressure (SBP) in heart failure (HF) with preserved ejection fraction carries a Class I recommendation but with limited evidence. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have antihypertensive effects across cardiovascular disease.

Details

Language :
English
ISSN :
22131779
Volume :
11
Issue :
1
Database :
Supplemental Index
Journal :
JACC: Heart Failure
Publication Type :
Periodical
Accession number :
ejs61471956
Full Text :
https://doi.org/10.1016/j.jchf.2022.09.002